Predict your next investment

Nu-Med Plus company logo
HEALTHCARE | Medical Devices & Equipment / Device Design & Manufacturing
nu-medplus.com

See what CB Insights has to offer

Stage

Unattributed | Alive

Total Raised

$80K

About Nu-Med Plus

Nu-Med Plus designs, develops and markets new patented technologies in the medical field along with building key intellectual assets. The company's strategy is to focus on high growth potential markets where there is a clearly defined need recognized by the medical community that can be addressed by Nu-Med Plus and its' technological expertise.

Nu-Med Plus Headquarter Location

455 East 500 South Suite #205

Salt Lake City, Utah, 84111,

United States

801-746-3570

Latest Nu-Med Plus News

Patent Issued for Single-Use or Short-Term Nitric Oxide Delivery Device

Sep 21, 2020

Patent Issued for Single-Use or Short-Term Nitric Oxide Delivery Device This patent will provide Nu-Med Plus the IP protection to pursue individual nitric oxide treatment options in emergency situations. Globe Newswire09.21.20   Nu-Med Plus Inc ., a medical device company which investigates and develops applications and devices for nitric oxide delivery in the medical field, announced that the U.S. Patent and Trademark Office  has issued U.S. patent #10682486 for a single-use or short-term use nitric oxide inhaler. This patent will provide the company the intellectual property protection to pursue individual nitric oxide treatment options in emergency situations. The company has designed the system to be used in remote or rural areas which may not have access to non-portable equipment. The portable system has the capability to rapidly deliver the prescribed dose of nitric oxide when critical care and instantaneous use is required either within or outside of traditional hospital settings. Typically, nitric oxide delivery devices are large, electronically complex devices that are used primarily in neonatal intensive care units. The importance of nitric oxide as a treatment is well documented in literature, but to date has not seen widespread use because of the bulky delivery equipment designed for hospital use and the high cost of the treatment. Jeff Robins, CEO of Nu-Med Plus, stated, “This published patent is a major accomplishment for our company and can help open new patient markets. We believe that this patent will give our company the opportunity to be on the forefront of re-shaping the inhaled nitric oxide market landscape,”

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Nu-Med Plus

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Nu-Med Plus is included in 1 Expert Collection, including Medical Devices.

M

Medical Devices

7,401 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. Excludes CDMOs/CMOs. *Columns updated as regularly as possible.

Nu-Med Plus Patents

Nu-Med Plus has filed 1 patent.

The 3 most popular patent topics include:

  • Breathing gases
  • Fluid dynamics
  • Gas technologies
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/31/2019

6/16/2020

Respiratory therapy, Fluid dynamics, Industrial gases, Gas technologies, Breathing gases

Grant

Application Date

1/31/2019

Grant Date

6/16/2020

Title

Related Topics

Respiratory therapy, Fluid dynamics, Industrial gases, Gas technologies, Breathing gases

Status

Grant

Nu-Med Plus Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Nu-Med Plus Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.